The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases?

• मुख्य लेखकों: Mitra Abbasifard (लेखक), Kowsar Bagherzadeh (लेखक), Hossein Khorramdelazad (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Clobenpropit is a histamine H3 receptor antagonist and has developed as a potential therapeutic drug due to its ability to inhibit CXCR4, a chemokine receptor involved in autoimmune diseases and cancer pathogenesis. The CXCL12/CXCR4 axis involves several biological phenomena, including cell prolifer...